Virology Market By Type 2022 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Virology Market
Virology Market: By Type (Diagnosing Test, Viral Infection Controlling Methods & others); By Application (Skin & Soft Tissue Infections, Respiratory Tract Infections & others); By End-User (Hospitals, Clinics, Laboratories & others) & By Region-Forecast (2016-2022)
Report Code : HCR 0423
Published: 07 October, 2016   No. of pages: 131

  • Report Description
  • Table of Contents
  • Customization Options
Virology is a branch of microbiological or pathological science which involves the study of viruses and virus-like agents. Virology focuses on the following aspects of viruses: their structure, classification and evolution, their ways to infect and exploit host cells for reproduction, their interaction with host organism physiology and immunity, the diseases they cause, the techniques to isolate and culture them, and their use in research and therapy. Globally, increasing instances of viral epidemic breakouts and huge R&D investment by major players are expected to remain key growth drivers for virology during the period of study.

Virology Market
 
Geographically, North America dominated the virology market driven by world class healthcare infrastructure with a technologically advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for virology market. Asia Pacific is projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the virology market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the virology market.

This report segments the virology market on the basis of type, application, end-user and regional market as follows:
  • Virology market research report is classified on the basis of type. Some of the major types covered in this report are as follows: Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons
  • Virology market research report is classified on the basis of application. Some of the major applications covered in this report are as follows: Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infections, Eye Infections, CNS Infections, Sexually Transmitted Diseases, Perinatal Infections
  • Virology market research report is classified on the basis of end-users. Some of the major end-users covered in this report are as follows: Hospitals, Clinics, Laboratories, Diagnostic Centres, Blood Banks, Pharmacies
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the virology market. Some of the major companies’ profiles in detail are as follows:
  • GlaxoSmithKline plc
  • Abbott Laboratories
  • Boehringer Ingelheim Corporation
  • Merck and Co. Inc.
  • Novartis International AG
1. Virology Market – Overview
2. Executive Summary 
3. Virology Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Virology Market– Forces
   4.1. Drivers
      4.1.1. Increasing incidences of global viral epidemics
      4.1.2. Growing applications of virology research in gene therapy, phage therapy, formulation of vaccines, and synthetic biology
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Virology Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Virology Market, By Type
   6.1. Diagnosing Test
   6.2. Viral Infection Controlling Methods
   6.3. Antiviral Chemotherapy
   6.4. Interferons
7. Virology Market, By Application
   7.1. Skin and Soft Tissue Infections
   7.2. Respiratory Tract Infections
   7.3. GI Tract Infections
   7.4. Urinary Tract Infections
   7.5. Eye Infections
   7.6. CNS Infections
   7.7. Sexually Transmitted Diseases
   7.8. Perinatal Infections
8. Virology Market, By End-User 
   8.1. Hospitals
   8.2. Clinics
   8.3. Laboratories
   8.4. Diagnostic Centres
   8.5. Blood Banks
   8.6. Pharmacies
9. Virology Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America 
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Virology Market – Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   11.1. GlaxoSmithKline plc
   11.2. Abbott Laboratories
   11.3. Boehringer Ingelheim Corporation
   11.4. Merck and Co. Inc.
   11.5. Novartis International AG
   11.6. Siemens
   11.7. Johnson & Johnson
   11.8. AstraZeneca AB
   11.9. Roche
   11.10. Abivax
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports